Bellevue Group »

Brookdale Senior Living shares owned by Bellevue Group

Quarter-by-quarter ownership of Brookdale Senior Living (BKD) shares owned by Bellevue Group from 13F filings

Historical chart of Bellevue Group investment in Brookdale Senior Living

Tip: Access up to 7 years of quarterly data

All positions including Brookdale Senior Living held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Brookdale Senior Living by Bellevue Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $887k 105k 8.47

More positions owned by Bellevue Group

Ionis Pharmaceuticals (IONS)
Argenx Se Sponsored Adr (ARGX)
Revolution Medicines (RVMD)
Neurocrine Biosciences (NBIX)
Alnylam Pharmaceuticals (ALNY)
Vertex Pharmaceuticals Incorporated (VRTX)
Abbott Laboratories (ABT)
Stryker Corporation (SYK)
Boston Scientific Corporation (BSX)
Intuitive Surgical Com New (ISRG)
Agios Pharmaceuticals (AGIO)
Incyte Corporation (INCY)
Scholar Rock Hldg Corp (SRRK)
Akero Therapeutics (AKRO)
Immunocore Hldgs Ads (IMCR)

View all positions for Bellevue Group

Top funds holding Brookdale Senior Living

BlackRock
Vanguard Group
Flat Footed
Antipodes Partners
Deerfield Management Company
Wellington Management Company
Renaissance Technologies
Carronade Capital Management
Maple Rock Capital Partners
Geode Capital Management
State Street Corporation
Dimensional Fund Advisors
Edmond De Rothschild Holding
Morgan Stanley
Deutsche Bank Aktiengesellschaft

View all funds holding Brookdale Senior Living